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Segments of viral fusion proteins play an important role in viral fusion. They are defined by a number of criteria, including the sensitivity
of this region of the viral fusion protein to loss of function as a consequence of mutation. In addition, small model peptides designed to mimic
this segment of viral fusion proteins often have some membrane perturbing activity. The properties of viral fusion peptides are quite varied.
Many are found at the amino terminus of viral fusion proteins. As isolated peptides, they have been found to form both a-helical as well as h-
structure. In addition, some viruses have internal fusion peptides. Just as there are several structural motifs for viral fusion peptides, there are
also several mechanisms by which they accelerate the process of membrane fusion. These include the promotion of negative curvature,
lowering the rupture tension of the lipid monolayer, acting as an anchor to join the fusion membranes, transmitting a force to the membrane
or imparting energy to the system by other means. It is not likely that the fusion peptide can fulfill all of these diverse roles and future studies
will elucidate which of these mechanisms is most important for the action of individual viral fusion peptides.D 2003 Elsevier B.V. All rights reserved.Keywords: Viral fusion; Fusion peptide; Peptide–membrane interaction1. What is a ‘‘fusion peptide’’?
Although the term fusion peptide has been widely used in
the literature, there is not a precise definition as to what this
term means. Furthermore, the term has been used both for a
short model peptide mimicking a segment of a fusion
protein as well as for the segment of the fusion protein
itself. In this review, we will use the term fusion peptide
only to refer to the small model peptide and we will call the
corresponding region of the fusion protein the fusion
peptide segment. This review will also focus on fusion
proteins from viruses, since more is known about these
systems and, in general, fewer proteins are involved in the
acceleration of viral fusion.
Despite the fact that there is no precise definition of the
term fusion peptide, for many viruses, there is little
disagreement about which region of the fusion protein
corresponds to the fusion peptide segment. There are a0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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ments. None of these criteria are absolute in defining a
fusion peptide segment, but in combination, they are
sufficiently restrictive to often allow the identification of
one region of the protein as being the fusion peptide
segment. The fusion peptide segment is often found to be
hydrophobic, rich in Gly residues and at the N-terminal end
of the fusion protein. Although this helps to identify fusion
peptide segments that meet these criteria, there are exam-
ples of other segments that have been identified as fusion
peptide segments that do not meet these criteria. Another
criterion is that mutation in the fusion peptide segment of
the fusion protein leads to loss of activity because of the
essential nature of the fusion peptide segment for mem-
brane fusion. Again, while this is a good generality, it is
not an absolute rule. For example, mutation of the amino
terminal Gly of the fusion peptide segment of influenza
virus can result in a variety of phenotypes, depending on
the nature of the amino acid substituted [1]. In addition,
there are many examples of mutations outside of the region
of the fusion peptide segment that result in loss of
fusogenic activity. The amino acid residues that are in-
volved in mutations leading to new strains of infectious
virus must be outside of the fusion peptide segment.
Hence, although some regions can be excluded as being
R.M. Epand / Biochimica et Biophysica Acta 1614 (2003) 116–121 117part of the fusion peptide segment, there is no single
criterion that can be used to positively identify a fusion
peptide.
In addition to properties of segments of the intact viral
fusion protein, a small synthetic peptide having a se-
quence corresponding to the fusion peptide segment will
have membrane-perturbing activity. These fusion peptides
rarely support non-leaky fusion with the mixing of the
aqueous contents of the fusing particles. They do, how-
ever, generally promote lipid mixing between liposomes
and more generally they destabilize membrane bilayers.
Because the action of these fusion peptides on mem-
branes is not very specific and there is no quantitative
criterion for the degree of membrane destabilization
expected for a fusion peptide, this property also does
not provide a clear criterion for defining a fusion peptide.
Despite the fact that there is no absolute criterion to
define what is and what is not a fusion peptide segment,
it is clear that certain segments of viral fusion proteins
have a more important role in the fusion process than
other segments.2. Conformational properties of fusion peptides
The information that one would really like to know is the
conformation of the fusion peptide segment of a viral fusion
protein in the presence of membranes. In general, however,
one is able to either obtain a detailed X-ray or nuclear
magnetic resonance (NMR) structure of a segment of the
ectodomain of a viral fusion protein as a crystal in the
absence of membranes or to study by NMR the conforma-
tion of a small synthetic fusion peptide, either in the
presence or absence of membranes.
A general assessment of the secondary structure of a
fusion peptide can be made using less specific spectroscopic
techniques, based on the properties of the amide chromo-
phores, such as circular dichroism or infrared spectroscopy.
Many viral fusion peptides have been found to be a-helical
when inserted into a membrane. This is not unanticipated,
since the insertion of amide groups into membranes is
energetically highly unfavorable [2], unless the amide
groups are hydrogen bonded, such as when they have a
high secondary structure content. In addition to the second-
ary structure, polarized attenuated total reflectance Fourier
transform infrared spectroscopy (ATR-FTIR) can be
employed to determine the orientation of a helical peptide
in a membrane. It has been found that many viral fusion
peptides are inserted into a membrane at an oblique angle
[3–5].
There have been attempts to obtain more specific
structural information using small angle neutron scattering
from oriented membranes with an inserted simian immu-
nodeficiency virus (SIV) viral fusion peptide containing
substituted deuterium atoms [6]. This work also suggested
that the insertion of the peptide was at an oblique angle.A more detailed structure of the influenza fusion peptide
was obtained using a combination of NMR of the fusion
peptide in micelles and spin label quenching of the
peptide in a membrane as a function of pH [7]. That
work demonstrated that the peptide had a conformation
that was not a simple helical structure and that a kink in
the peptide played an important role in changing the
depth of insertion of the peptide as a function of pH
[7,8].
In addition to fusion peptides being a-helices or partially
a-helical, there is also some evidence for viral fusion
peptides having h-structure. Most proteins that insert into
membranes as h-structures do so as h-barrels, in which
there is no ‘‘edge’’ with unfulfilled hydrogen bonding.
There is also the possibility of the model fusion peptides
aggregating as h-structures on the surface of the membrane.
In the case of the intact fusion protein, it is difficult to see a
priori how a sufficient number of fusion proteins can cluster
together to have their fusion peptide segments associate to
form a h-barrel. Nevertheless, there is evidence that the
fusion peptide of HIV can form a h-structure at the amino
terminus [9,10].
In addition to these two types of fusion peptides, there
are also internal fusion peptides, whose sequence suggests
that they do not form extensive secondary structures. These
include an internal peptide of avian leukosis and sarcoma
virus [11–13], vesicular stomatitis virus G-protein [14] and
the non-enveloped fusogenic avian and Nelson Bay reovi-
ruses [15].3. Curvature modulation by fusion peptides
A common property of a number of fusion peptides is
that they lower the bilayer to hexagonal phase transition
temperature (TH) of phosphatidylethanolamine, indicating
that they promote negative curvature [16]. This property is
well correlated with conditions that lead to membrane
fusion. Thus for example, the fusion peptide from influ-
enza virus lowers TH at acidic pH where the virus is
fusogenic, but not at neutral pH where the rate of fusion is
slow [17]. In addition, there is a correlation between the
fusion activity of viral mutants and the ability of their
fusion peptide to lower TH, both with influenza virus [18]
as well as with SIV [19,20]. The promotion of negative
curvature by fusion peptides is in accord with the require-
ment to increase the negative curvature of the contacting
monolayers to form the hemifusion intermediate [21,22]. It
also may help to explain the common finding that fusion
peptides insert into a membrane as a tilted helix. Such an
orientation of the inserted helical segment is consistent
with the observation that the peptide promotes negative
curvature, since it would be anticipated that such an angle
of insertion would have a greater effect in expanding the
region in the center of the bilayer than at the membrane
interface.
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The fusion peptide has been shown to insert into target
membranes, at least in some stage of the fusion process [23].
This may be an important component in bridging the two
fusing structures. In addition, it has been suggested that the
inserted fusion peptide segment may be an attachment to the
membrane that allows a conformational rearrangement (see
below) of the protein to transmit a force to the membrane
[24].5. Membrane rupture tension
In order for two bilayers to merge into one, each
monolayer must rupture and reform. The energy required
to break the membrane will be dependent on its rupture
tension. It has been shown that low concentrations of the
order of 1% of hydrophobic peptides, including Lys–
Leu16–Lys [25] and the influenza fusion peptide [26],
lower the rupture tension of membranes. This property has
been used to explain the ability of the influenza virus to
promote the formation of cubic phases [27]. This pro-
posed role for the fusion peptide to lower the rupture
tension is independent of membrane curvature. It would
require the fusion peptide to access the trans monolayer to
rupture it so as to form a fusion pore. It is possible that
both the promotion of negative curvature and the lowering
of membrane rupture tension are important for accelerat-
ing the rate of membrane fusion at different stages of the
process.6. Fusogenic activity of model fusion peptides
In general, synthetic viral fusion peptides are much less
effective in accelerating membrane fusion compared with
the intact fusion protein. It of course is not surprising that a
small peptide, generally less than 25 residues in length,
does not reproduce all of the functions of an intact protein
of tens of kilodaltons. There are at least two factors that are
likely to contribute to the greater activity of the intact
protein. One is that viral fusion proteins form stable multi-
mers and in addition they tend to self-associate in mem-
branes to form higher order complexes [28,29]. Thus, the
fusion peptide segment does not function as an isolated
unit, but is rather assembled into an organized complex in
which several fusion peptide segments can act in a coordi-
nated fashion.
In addition, there are other regions of the fusion protein
that our outside of the fusion peptide but can also participate
in accelerating fusion. Evidence for a role of the transmem-
brane segment and the cytoplasmic tail of the fusion protein
has recently been summarized [30]. In this article, we will
focus on the role of other regions of the ectodomain of the
fusion protein.Isolated fusion peptides promote contents leakage of
vesicles [31] and therefore true fusion, or mixing of aqueous
contents cannot be measured [32]. Other regions of the viral
proteins, apart from the fusion peptide, are required for
binding to allow the two fusing structures to become
juxtaposed. In addition, other segments of the viral protein
are important for the evolution of the hemifusion interme-
diate into a fusion pore. Even a large 127-amino-acid
ectodomain fragment of the HA2 chain of the influenza
virus hemagglutinin does not efficiently promote full fusion
[33]. To monitor the mixing of aqueous contents, the rate of
formation of a fusion pore has to be more rapid than the rate
of leakage. However, an agent that will destabilize mem-
brane bilayers will induce leakage. Even many intact viruses
induce hemolysis and it has been found that influenza virus
causes the lysis of liposomes [34]. It is therefore not
surprising that a small fragment of the viral fusion protein,
the fusion peptide, causes sufficient leakage to prevent
measuring the mixing of aqueous contents.7. Other regions of the viral fusion protein
It has been shown that a construct corresponding to the
major portion of the ectodomain of the HA2 chain of the
influenza hemagglutinin protein, is many fold more active in
inducing lipid mixing than is the fusion peptide of this same
protein. This construct maintains the pH dependence of
fusion rate found for the native virus [35]. There are also
other cases of viral proteins that have N-terminal fusion
peptides, but also contain other segments of the ectodomain
that contribute to the fusion mechanism [36]. One example
is Sendai virus that has a segment adjacent to, but indepen-
dent of, the N-terminal fusion peptide. This is based on the
orientation of the proximal segment along the plane of the
membrane, rather than being inserted into the membrane as
is the fusion peptide [37,38]. This internal peptide is part of
the heptad repeat motif. A similar arrangement has been
shown for another paramyxovirus, measles [39], suggesting
the possibility that this is a general characteristic of this
class of viruses. In addition, HIV-1, a retrovirus, has a
segment of the heptad repeat that binds to membranes in
addition to stabilizing a trimeric structure [40]. These
peptides do not insert deeply into the membrane, as do the
fusion peptides. The presence of aromatic residues is im-
portant for stabilizing the peptide in a membrane region
close to the interface [2]. This property has been used to
identify regions of the ectodomain of viral fusion proteins
that interact with the membrane surface and facilitate fusion
[41,42].8. Energy that drives the fusion reaction
There has been discussion in the literature about the
‘‘source of energy for fusion’’. It should be remembered,
Table 1
Segments of class I viral fusion proteins
Segment Properties Putative role
Fusion peptide Frequently found at
amino terminus.
Maybe a-helical or
h-structure.
Hydrophobic. High
content of Gly.
Inserts into target membrane.
Destabilizes bilayer.
Promotes negative curvature
to facilitate stalk formation.
Lowers bilayer rupture
tension to promote formation
of fusion pore.
Heptad repeat Triple helical
coiled-coil structure
Contributes to cooperativity
among fusion peptides.
Other specific
regions of
ectodomain
Various. Maybe
surface seeking helix.
Greatly potentiates action of
fusion peptide, possibly
dehydrates membrane surface.
Transmembrane
helix
Hydrophobic helix Ties viral membrane to fusion
apparatus in ectodomain.
Promotes self-association of
viral protein. May facilitate
partitioning of fusion protein
into membrane domains.
Cytoplasmic tail Variable Differing importance,
according to specific example.
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of the starting structures and of the products is similar. There
is a similar morphology of both reactant and end product, in
which the bilayer is essentially flat on a molecular scale.
The fusion protein may undergo some change in structure,
but it is not initially in a metastable high-energy state, at
least in the case of the influenza hemagglutinin protein
[43,44]. The function of the fusion protein is to lower the
activation energy for membrane fusion. The intermediate
structures as well as the transition states in the fusion
process are of higher energy than either the starting struc-
tures or the products since these intermediates will include
the bending and transient rupture of monolayers, processes
that do not occur spontaneously. The fusion protein may
contribute energy to allow more rapid formation of the
intermediates that are formed in the pathway to fusion. In
this sense, the fusion protein may participate in a process
that yields energy that is coupled with the reorganization of
membrane lipids to facilitate fusion. There are several
alternative explanations that have been proposed for the
process that gives rise to this energy. Since there is such a
large conformational change of the influenza hemagglutinin
protein upon acidification [45], an attractive hypothesis is
that this conformational change is coupled with the release
of energy that can facilitate the formation of fusion inter-
mediates. Although there is no high energy, metastable state
as a consequence of the constraints placed on HA2 by the
presence of the surrounding HA1 subunits, there could be an
increase in the energy of the protein following acidification.
Electrostatic calculations have shown that there is increased
repulsion among HA1 subunits as a consequence of acidi-
fication [46]. If the release of this electrostatic repulsion as a
consequence of the loosening of the oligomeric structure of
the hemagglutinin protein could be coupled with changes in
the organization of the lipid, this could impart an energy that
could accelerate the fusion process.
The fusion peptide segment is sequestered within the
structure of the hemagglutinin protein before fusion [47].
When this segment becomes exposed during the confor-
mational rearrangement of the protein, a subsequent inser-
tion of the hydrophobic fusion peptide segment into a
membrane would be expected to liberate energy that could
be coupled with membrane fusion. A less direct coupling
of the insertion of the fusion peptide segment into a
membrane with a resulting facilitation of membrane fusion
has been proposed. In this hypothesis, the fusion peptide is
initially inserted into the viral membrane. As a conse-
quence of the conformational rearrangement of the ectodo-
main, there is a force transmitted to the membrane by
pulling on the fusion peptide [24]. This process creates a
dimpling of the membrane that would destabilize the
bilayer and be a site for the initiation of membrane fusion.
It has also been pointed out that the fusion peptide segment
does not function as an isolated monomeric structure, but
rather a cooperative interaction among fusion proteins
occurs [28].9. Conclusions
The mechanism by which proteins facilitate the forma-
tion of fusion intermediates is a complex process involving
several segments of fusion proteins (Table 1). The best
understood fusion mechanism is that of the fusion of
enveloped viruses with target membranes. However, even
this process is not simple and there are significant differ-
ences in the mechanism among different viruses.
A component of the acceleration of fusion by these
fusion proteins is the interaction with the membrane of the
fusion peptide segment. This segment is not the sole factor
in promoting fusion, but in several cases, it has been shown
to be an essential component. There are several hypotheses
for the mechanism by which this segment of the fusion
protein accelerates the formation of fusion intermediates.
One of the most developed examples is that of the fusion
peptide segment of influenza virus that has the additional
feature that its action is strongly pH dependent. This can be
a combined consequence of the change in membrane
insertion as a function of pH [7] or as a result of the
formation of an extended coiled-coil as a result of the
conformational rearrangement of the hemagglutinin protein.
This later conformational change is a requirement for fusion
with the intact protein to make the fusion peptide segment
accessible. As a consequence, mutations that alter the pH
dependence of the fusion peptide may have no discernable
effects on the kinetic properties of fusion catalyzed by the
intact protein [48]. However, this conformational rearrange-
ment is required only to expose the segments of the fusion
protein required for rapid fusion, but not for the fusion
process itself, since a fragment of HA2, already in the
extended coiled-coil form at neutral pH, does not promote
fusion until the pH is lowered to close to 5 [33,35]. Thus,
R.M. Epand / Biochimica et Biophysica Acta 1614 (2003) 116–121120many factors contribute to the potency and regulation of the
activity of fusion proteins. Although the detailed structure of
major portions of the ectodomain of influenza virus have
been known for several years, there are still many questions
to be answered regarding the mode of action of this protein
and others in accelerating membrane fusion reactions.References
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